# Investigation of Flare and Remission in Subjects With Atopic Dermatitis

> **NCT03710044** · PHASE4 · WITHDRAWN · sponsor: **LEO Pharma**

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** Cyclosporine A

## Key facts

- **NCT ID:** NCT03710044
- **Lead sponsor:** LEO Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-01-14
- **Primary completion:** 2020-08
- **Final completion:** 2020-08
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Strategic decision
- **Last updated:** 2024-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03710044

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03710044, "Investigation of Flare and Remission in Subjects With Atopic Dermatitis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03710044. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*